Curexo Inc
Curexo Inc operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.
Business. Curexo Inc (060280.KQ) is a food and drug retailing company listed on the KOSDAQ exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on food retail and distribution activities. No specific operating segments or geographic breakdowns are provided in the available data. The company is headquartered in South Korea, consistent with its primary listing on the Korean exchange.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Curexo Inc (060280.KQ) is a food and drug retailing company listed on the KOSDAQ exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on food retail and distribution activities. No specific operating segments or geographic breakdowns are provided in the available data. The company is headquartered in South Korea, consistent with its primary listing on the Korean exchange.
Curexo Inc maintains a strong liquidity position, with a current ratio of 20.69 and cash and equivalents amounting to 18,687,406,190 KRW, indicating a robust ability to meet short-term obligations. The company's debt-to-equity ratio is 0.01, suggesting a conservative capital structure with minimal reliance on debt financing. Despite a negative operating cash flow of -11,258,378,660 KRW, the company's free cash flow of 3,043,336,520 KRW supports ongoing operations and potential reinvestment.
Profitability metrics for Curexo Inc show a return on equity (ROE) of 2.88% and a return on assets (ROA) of 2.74%, which are below the industry median for the Food Retail & Distribution sector. The company's gross profit margin is 33.33%, and its operating margin is 3.17%, both of which are in line with the sector median. However, the company's net income of 2,771,488,550 KRW indicates a solid bottom-line performance.
Curexo Inc's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification. The company's revenue is primarily derived from a single business line, which may expose it to higher operational and market risks. The company's market share is not disclosed, but its revenue of 74,531,816,400 KRW suggests a significant presence in the industry.
The company's growth trajectory is mixed. Analysts estimate a mean revenue of 241,066,670,000 KRW for the current fiscal year, representing a substantial increase from the last actual revenue of 74,545,000,000 KRW. However, the mean EPS estimate of 140.25 KRW is significantly higher than the last actual EPS of 67.00 KRW, indicating potential volatility in earnings. The company's capital expenditure of -2,513,503,320 KRW suggests a focus on cost management and efficiency.
Risk factors for Curexo Inc include low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong equity position mitigate credit risk. However, the high price-to-earnings ratio of 192.74 and price-to-book ratio of 5.55 suggest that the stock may be overvalued relative to its fundamentals. The company's conservative capital structure and strong liquidity position reduce the likelihood of near-term dilution.
Recent events and filings for Curexo Inc do not indicate any significant changes in the company's financial or operational status. The company's recent performance and analyst estimates suggest a potential for growth, but the high valuation multiples may pose a challenge for sustaining investor confidence.
- Curexo Inc has a strong liquidity position with a current ratio of 20.69 and significant cash reserves.
- The company's profitability metrics, including ROE and ROA, are below the industry median, indicating room for improvement.
- Revenue is concentrated in a single segment, which may increase operational and market risks.
- Analyst estimates suggest potential revenue and EPS growth, but the high valuation multiples may pose a challenge.
- The company's conservative capital structure and low debt levels reduce credit and dilution risks.
- "margin_outlook_rationale": "The company's gross profit margin is in line with the sector median, but the operating margin is below the median, indicating potential cost management challenges.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 140,25 |
| Revenue | —no estimate | —no estimate | 241,1B KRW |
| Operating income | —no estimate | —no estimate | 6,2B KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Curexo Inc Market data — financials · 2026-05-26
- Curexo Inc Market data — analyst estimates · 2026-05-26